Historically, academia has been breeding ground for groundbreaking discoveries. But often these findings remained confined within Academic Journals lacking the pathway to real world applications. However, as technology transfer offices popped up around universities around the world, entrepreneurial programs, catalysts, collaborative initiatives, universities are more and more recognizing the value of translating their research into products and therapies that can benefit society. As communities around the world grapple with complex health challenges, there's a growing pressure to deliver innovative solutions in a timely manner. This has driven academia to actively engage in commercialization and look at it as a means to fund science students and really just keep the lights on in many labs. So, that's what we'll explore this episode. Why does commercialization take place? Why should academics even bother? And is it a driving force for innovation? We'll learn from some real efforts that have been occurring here at the University of Toronto, and those that have been involved in them. Featured Guests Dr. Paul Santerre Professor & Baxter Chair in Health Technology & Commercialization at University of Toronto's Institute of Biomedical Engineering and University Health Networks Director, Health Innovation Hub Dr. Christine Allen Professor, Leslie Dan Faculty of Pharmacy, University of Toronto Co-founder and CEO, Intrepid Labs